We are live on ! Find out more
OMCL icon

Omnicell

299 hedge funds and large institutions have $3.55B invested in Omnicell in 2019 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 124 increasing their positions, 95 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

31% more repeat investments, than reductions

Existing positions increased: 124 | Existing positions reduced: 95

14% more funds holding in top 10

Funds holding in top 10: 78 (+1)

9% more capital invested

Capital invested by funds: $3.27B → $3.55B (+$289M)

1.25% more ownership

Funds ownership: 99.03%100.28% (+1.2%)

5% less first-time investments, than exits

New positions opened: 36 | Existing positions closed: 38

2% less funds holding

Funds holding: 306299 (-7)

84% less call options, than puts

Call options by funds: $2.85M | Put options by funds: $17.7M

Holders
299
Holders Change
-7
Holders Change %
-2.29%
% of All Funds
6.46%
Holding in Top 10
8
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+14.29%
% of All Funds
0.17%
New
36
Increased
124
Reduced
95
Closed
38
Calls
$2.85M
Puts
$17.7M
Net Calls
-$14.8M
Net Calls Change
-$17.5M

OMCL Hedge Fund Activity: Q2 2019 in Review

299 of the 4,625 institutional investors tracked by Wall St. Rank reported a position in Omnicell (OMCL) for Q2 2019, worth a combined $3.55B — up 8.8% from $3.27B a quarter earlier.

Sellers outnumbered buyers: 38 funds closed out of OMCL and 36 opened new positions — a net loss of 2 holders — while 95 trimmed existing stakes and 124 added.

The largest buyer was Invesco, adding an estimated $28.1M. The largest seller was Bank of New York Mellon, cutting an estimated $27.9M.

  • 299 institutional investors held Omnicell (OMCL) as of Q2 2019, down from 306 in Q1 2019.
  • Funds reported $3.55B of Omnicell stock for Q2 2019, up 8.8% quarter-over-quarter.
  • 36 funds opened new Omnicell positions in Q2 2019 and 38 closed out, a net change of -2 holders.
  • The largest Omnicell buyer in Q2 2019 was Invesco, an estimated $28.1M added.
  • The largest Omnicell seller in Q2 2019 was Bank of New York Mellon, an estimated $27.9M sold.

Based on aggregated 13F filings for Q2 2019.